跳至主要内容
临床试验/CTRI/2017/01/007689
CTRI/2017/01/007689进行中(未招募)2 期

A Randomized parallel group clinical trial on effectiveness of Ayurvedic medicines in reducing adverse effects of radiotherapy, improving disease free survival and quality of life assessed by criteria such as CTCAE, Karnofsky score and QLQ by EORTC, and assessing systemic immune response and oxidative stress of oral cancer patients

Dr Shweta Gujar0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Oral cavity cancer patients of all stages and grades, who are scheduled for radiotherapy (dose up to 6600 cGY in 30-35 fractions in 5-6 weeks), who are also treated with or without concurrent chemotherapy (Inj. Cisplatin, as booster therapy to radiotherapy)

排除标准

  • Oral cavity cancer patients who have already received palliative radiotherapy and patients receiving curative chemotherapy along with radiotherapy

研究者

发起方
Dr Shweta Gujar

相似试验